08:09 AM EDT, 08/28/2024 (MT Newswires) -- 23andMe Holding's ( ME ) subsidiary Lemonaid Health said Wednesday it is offering Ozempic, Wegovy and compounded semaglutide through a weight loss program on its telehealth platform.

The company said it would provide customers access to GLP-1 drugs through a convenient subscription-based model.

Shares of the company added over 8% in recent premarket activity.

Price: 0.3499, Change: +0.03, Percent Change: +8.40